Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-11-058219
Filing Date
2011-11-28
Accepted
2011-11-28 18:02:03
Documents
1
Period of Report
2011-11-01

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 3437
  Complete submission text file 0001209191-11-058219.txt   4771
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Issuer) CIK: 0000816284 (see all company filings)

EIN.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CELGENE CORPORATION 106 ALLEN ROAD BASKING RIDGE NJ 07920
Business Address
FOUSE JACQUALYN A (Reporting) CIK: 0001405288 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-34912 | Film No.: 111229281